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Brucella abortus, the causative agent of bovine brucellosis, invades and replicates within
cells inside a membrane-bound compartment known as the Brucella containing vacuole
(BCV). After trafficking along the endocytic and secretory pathways, BCVs mature
into endoplasmic reticulum-derived compartments permissive for bacterial replication.
Brucella Type IV Secretion System (VirB) is a major virulence factor essential for the
biogenesis of the replicative organelle. Upon infection, Brucella uses the VirB system
to translocate effector proteins from the BCV into the host cell cytoplasm. Although
the functions of many translocated proteins remain unknown, some of them have been
demonstrated to modulate host cell signaling pathways to favor intracellular survival
and replication. BPE123 (BAB2_0123) is a B. abortus VirB-translocated effector protein
recently identified by our group whose function is yet unknown. In an attempt to identify
host cell proteins interacting with BPE123, a pull-down assay was performed and
human alpha-enolase (ENO-1) was identified by LC/MS-MS as a potential interaction
partner of BPE123. These results were confirmed by immunoprecipitation assays. In
bone-marrow derived macrophages infected with B. abortus, ENO-1 associates to
BCVs in a BPE123-dependent manner, indicating that interaction with translocated
BPE123 is also occurring during the intracellular phase of the bacterium. Furthermore,
ENO-1 depletion by siRNA impaired B. abortus intracellular replication in HeLa cells,
confirming a role for α-enolase during the infection process. Indeed, ENO-1 activity
levels were enhanced upon B. abortus infection of THP-1 macrophagic cells, and this
activation is highly dependent on BPE123. Taken together, these results suggest that
interaction between BPE123 and host cell ENO-1 contributes to the intracellular lifestyle
of B. abortus.
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INTRODUCTION
The intracellular pathogen Brucella abortus is the causative agent
of bovine brucellosis, a worldwide zoonotic disease (Pappas
et al., 2005; Moreno, 2014). Brucella infection causes abortion
and sterility in animals, and undulating fever and debilitating
disorders in humans. Brucellosis remains endemic in many
countries, resulting in a serious public health problem and
economic losses (de Figueiredo et al., 2015).
Brucellae are able to replicate in a wide range of mammalian
cell types, including epithelial cells, fibroblasts, microglia, and
endothelial cells. However, the pathogen primarily infects
phagocytic cells, such as macrophages and dendritic cells in vivo
(Billard et al., 2005; Copin et al., 2007; Salcedo et al., 2008;
Archambaud et al., 2010). Bacteria survive and replicate within
these professional phagocytic cells prior to their dissemination
to placental trophoblasts (in pregnant females), reproductive
tract and the mononuclear phagocyte system, where they persist
to establish a long-term infection in the host and eventually
produce cardiovascular, hepatic, neurologic and osteoarticular
disease (Adams, 2002; Atluri et al., 2011).
Once internalized, Brucella resides in a membrane-bound
compartment known as the Brucella-containing vacuole (BCV).
BCV maturation is a multistep process in which the bacterium
actively controls the transient interactions and fusions of the
BCV with vesicles of the endocytic and secretory pathways. The
process allows the bacterium to evade killing in phagolysosomes
and ensures replication in an endoplasmic-reticulum-derived
compartment (Arenas et al., 2000; Celli and Gorvel, 2004;
Starr et al., 2008). BCVs first interactions with early and late
endosomes are followed by controlled fusion with lysosomes
and accumulation of late endosomal markers like Rab 7 and
LAMP1 (Celli et al., 2003; Starr et al., 2008). Then, endosomal
BCVs (eBCVs) are targeted to the early secretory pathway where
they interact with endoplasmic reticulum exit sites (ERES) and
fuse with endoplasmic reticulum (ER) membranes to originate
replicative organelles termed rBCVs (Celli et al., 2003, 2005).
Finally, BCVs mature into compartments with autophagic
features (aBCVs) which are required for cell-to-cell spreading
(Starr et al., 2012).
Biogenesis of the rBCV absolutely requires the Type IV
Secretion System (VirB), a major virulence factor and a
supramolecular machinery dedicated to deliver effector proteins
into the host cell cytoplasm (Hong et al., 2000; Sieira et al., 2000;
Comerci et al., 2001; Celli et al., 2003; de Jong et al., 2008; de
Barsy et al., 2011; Marchesini et al., 2011; de Jong et al., 2013;
Myeni et al., 2013; Salcedo et al., 2013; Döhmer et al., 2014). To
date, several B. abortus effectors have been identified. VceA and
VceC were the first VirB substrates identified on the basis of their
genes being co-regulated with the virB operon (de Jong et al.,
2008). Whereas VceA function remains to be described, it was
recently reported that VceC induces an inflammatory response by
triggering UPR-dependent NF-κB signaling (de Jong et al., 2013).
Another screening approach using yeast-two hybrid served to
identify RicA, a protein that interacts with host Rab2 and affects
BCVs traffic (de Barsy et al., 2011). More recently, an in silico
screening identified five additional VirB substrates, with three
of them (BspA, BspB, and BspF) targeting the cell secretory
pathway and interfering with host protein secretion (Myeni
et al., 2013). SepA, a VirB effector also identified by means of a
bioinformatics screening, was shown to participate in the early
stages of B. abortus intracellular survival (Döhmer et al., 2014).
BtpA and BtpB (Brucella TIR domain containing proteins A and
B), are translocated into host cells and down-modulate activation
of dendritic cells (Salcedo et al., 2008, 2013), whereas TcpB, the
B. melitensis BtpA homolog, induces the upregulation of UPR
target genes (Smith et al., 2013). Another combined in silico/in
vivo-based approach led us to the identification of four new VirB
substrates: BPE123, BPE043, BPE005, and BPE275 (Marchesini
et al., 2011). BPE005 is a cyclic nucleotide binding protein
that induces collagen deposition and matrix metalloproteinase 9
downmodulation via transforming growth factor β1 in hepatic
stellate cells (Arriola Benitez et al., 2016). BPE043 and BPE275
roles in Brucella pathogenesis remain to be uncovered. BPE123
is a small hypothetical protein with no conserved domains
other than a central coiled coil motif. Survival and intracellular
replication of a B. abortus bpe123 deletion mutant is similar to
the wild type in infected cells and in experimentally infected mice
(Marchesini et al., 2011). These features make BPE123 function
prediction a difficult task. We reasoned that the identification of
host cells proteins interacting with BPE123 would provide some
insight into its possible role during Brucella infection.
In this study, we identified human alpha-enolase (ENO-1)
as a BPE123 interacting partner that is associated to the BCVs
in a BPE123-dependent manner. Moreover, ENO-1 depletion in
infected cells served to identify this protein as a novel host cell
factor involved in B. abortus intracellular replication and whose
activity was enhanced in macrophages infected with B. abortus
and in HeLa cells ectopically expressing BPE123.
MATERIALS AND METHODS
Bacterial Strains, Plasmids and Growth
Conditions
Bacterial strains and plasmids used in this study are listed in
Table 1.
Brucella abortus strains were inoculated in tryptic soy agar
(TSA) (Difco/Becton-Dickinson, Sparks, MD) or in tryptic soy
broth (TSB) at 37◦C on a rotary shaker for 16-20 h. When
indicated, media were supplemented with 50µg/ml kanamycin,
5µg/ml nalidixic acid, and/or 50µg/ml ampicillin. All work
with live B. abortus was performed in a biosafety level 3
laboratory facility. Escherichia coli strains were grown in Luria
Broth (LB) liquid medium, or after addition of agar on plates,
at 37◦C overnight. Antibiotics, when required, were added at
the following concentrations: 50µg/ml kanamycin or 100µg/ml
ampicillin.
Plasmids
Plasmids used in this study are listed and described in
Table 1. To tag BPE123 with 6xHis for protein expression
and purification, the open reading frame coding for full
length BPE123 was PCR-amplified from genomic DNA of
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TABLE 1 | Bacterial strains and plasmids used in this study.
Strain or plasmid Characteristics (*) References or sources
B. abortus STRAINS
2308 Wild type, smooth, virulent, Nalr Laboratory stock
2308 mCherry 2308 Nalr containing pTRC_mCherry, Ampr This work
∆bpe123mCherry ∆bpe123Nalr containing pTRC_mCherry, Ampr This work
∆bpe123mCherry + pBPE123_3xFLAG ∆bpe123NalrAmpr, containing pTRC_mCherry and pBBR1 MCS-2 encoding
BPE123_3xFLAG, Kmr
This work
E. coli STRAINS
K12- DH5α (F’Iq) F’880dlacz1M15 1(lacZYA-argF)U169 deoR recA1 endA1hsdR17 (rK+mK+)
phoA supE44 λ-thi-1 gyrA96 relA1/F’proAB+ LacIqZ1M15 zzf::Tn5 (Kanr)
Woodcock et al., 1989
S17.1 (λpir) recAthi pro hsdR [res- mod+][RP4::2-Tc::Mu-Km::Tn7] λpir phage lysogen Herrero et al., 1990
PLASMIDS
pBBR1 MCS-2 Broad-host-range cloning vector, Kanr Kovach et al., 1995
pBPE123_3xFLAG pBBR1 MCS-2 encoding full length BPE123_3xFLAG, Kanr This work
pMyc_SerB pCMVMyc encoding full length SerB, Ampr This work
pMyc_BPE123 pCMVMyc encoding full length BPE123, Ampr This work
pQE30_BPE123 pQE30 encoding 6xHis_BPE123 This work
pTRC_mCherry pBBR1 MCS-4 encoding fluorescent protein mCherry under TRC promoter, Ampr Guidolin et al., 2015
pGShin2 Silencing vector encoding EGFP, Ampr Kojima et al., 2004
(*) Ampr , ampicillin resistance; Nalr , nalidixic acid resistance; Kmr , kanamycin resistance.
B. abortus 2308 with primers CGGGATCCATGAGCTTGTTGC
TGGCTAAC and TCCCCGCGGTCATGCCTGTCCCGCCAG
TTC containing BamHI and SacII restriction sites, respectively
(underlined). The PCR amplification product was cloned into
pGem-T-Easy and the DNA fragment coding for BPE123 was
excised by digestion with BamHI and PstI. This fragment was
ligated to the same sites of pQE30 (Qiagen) to generate plasmid
pQE30_BPE123, encoding a protein fusion to an N-terminal
6xHis tag. This plasmid was sequenced to confirm the construct,
and E. coli strain M15 [pREP4] (Qiagen), which permits high
levels of protein expression, was used as a host. M15 contains
a low-copy pREP4 plasmid which confers kanamycin resistance
and constitutively expresses the lac repressor protein encoded by
lacI gene. E. coli M15 strain does not contain a chromosomal
copy of lacI and therefore, pREP4 was maintained by selection
for kanamycin resistance.
To tag BPE123 with Myc tag for HeLa cells transfection,
the sequence coding for BPE123 was amplified by PCR
from B. abortus 2308 genomic DNA with forward primer
CGGAATTCCAATGAGCTTGTTGCTGGCTAA containing
EcoRI restriction site (underlined), and the reverse primer
GCCTCGAGTCATGCCTGTCCCGCCAGTTC, containing
XhoI site (underlined). The PCR amplification product was
digested with EcoRI and XhoI and cloned into the same
sites of pCMV-Myc vector (Clontech) to generate plasmid
pMyc_BPE123. In order to amplify the DNA sequence coding
for SerB (BAB1_1410), PCR was performed with forward
primer CGGAATTCCATCGCAGCAGGTTTCTCTCGTC and
reverse primer GCCTCGAG TTATTGGACGAAATCTGC
CTT, containing EcoRI and XhoI restriction sites, respectively
(underlined). The PCR amplification product was digested with
EcoRI and XhoI and cloned into the same sites of pCMV-Myc
vector to generate plasmid pMyc_SerB. The plasmids were
sequenced to confirm the constructs.
To obtain a plasmid coding for BPE123_3xFLAG (for
complementation of 1bpe123) with antibiotic resistance to
kanamycin, a BamHI/XbaI DNA fragment encoding the fusion
protein was excised from pBPE123_3xFLAG (Ampr) (Marchesini
et al., 2011), and ligated into the corresponding sites of pBBR1
MCS-2 (Kanr) to generate pBPE123_3xFLAG (Kmr). mCherry-
tagged B. abortus strains were obtained after introducing a
pBBR1-MCS-4 derivative encoding the fluorescent protein under
TRC promoter control (Guidolin et al., 2015). All plasmids were
introduced in B. abortus strains by biparental mating.
Cell Transfection and Confocal Microscopy
HeLa cells were seeded on 12-mm coverslips in 24-well plates
at 5 × 104 cells per well. After 24 h, cells were transfected
with pMyc_BPE123 or pMyc_SerB using Lipofectamine 3000
(Invitrogen), according to the manufacturer’s instructions. At
24 h post-transfection, cells were washed three times with PBS
and fixed with 4% paraformaldehyde (pH 7.4) for 15min at
37◦C. Fixed cells were washed again twice and coverslips were
incubated for 30 min in blocking buffer (PBS with 10% horse
serum and 0.1%saponin) and for 60 min in blocking buffer
containing primary antibodies. After two washes in 0.1% saponin
PBS, the coverslips were incubated for 60 min in blocking
buffer containing secondary antibodies. Finally, the coverslips
were washed three times in PBS and once in milli Q water
and mounted on glass slides using Fluorsave (Calbiochem).
The primary antibodies used were rabbit anti-ENO-1 (Santa
Cruz) and mouse anti-cMyc clone 9E10 (Developmental Studies
Hybridoma Bank, National Institute of Child Health and Human
Development, University of Iowa). The secondary antibodies
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used were Alexa Fluor 488 goat anti-mouse IgG and Alexa
Fluor 568 goat anti-rabbit IgG (Molecular Probes, Invitrogen).
Confocal images were acquired using a IX-81 microscope
attached to a FV-1000 confocal module, with a PLAN APO
60X NA 1.42 oil immersion objective (Olympus, Japan). The
acquisition software used was FV 10-ASW 3.1. Images were
treated using ImageJ 1.45s Software (NIH, USA), and images
of 1024 x 1024 pixels were then assembled using Adobe
Photoshop CS.
Protein Purification and Pull Down
Escherichia coli M15 cells harboring pQE30_BPE123 construct
were inducedwith 1mM IPTG for 3 h at 37◦C. The overexpressed
protein was purified by metal affinity chromatography with
Ni-Sepharose High Performance (GE) using a batch protocol
according to the manufactures instructions. E. coli extracts
and purified protein were separated on 15% SDS-PAGE to
assess the expression and purification. The purified recombinant
protein was designated as His_BPE123 and its concentration
was estimated by Bradford assay. Recombinant histidine-tagged
BPE123 was used to prepare polyclonal antibodies against
BPE123 by using a standard scheme of immunization in
C57BL/6J mice.
Pull-down assays were performed to detect potential
interactions between His_BPE123 and eukaryotic proteins
by using the ProFound Pull-Down Protein Interaction Kit
(Thermo Scientific Product no. 21277), as described by the
manufacturer. Briefly, 200µg His_BPE123 acting as bait was
allowed to adsorb to immobilized cobalt chelate gels for 3 h
at 4◦C in a rotating wheel. After thorough washing to remove
any unbound bait protein, prey proteins from HeLa soluble
cell lysates (SCL), obtained as described below, were incubated
with immobilized bait protein ON at 4◦C in a rotating wheel.
In control experiments, SCL were incubated with cobalt chelate
gels without bound His_BPE123. Columns were then washed
five times with binding buffer (50mM TrisHCl pH 7.6, 150mM
sodium chloride, 1.0% NP-40) followed by elution of the bound
complexes with 290mM imidazole. Sample and control were
run on a 10% SDS PAGE gel, silver stained and bands unique to
the sample were excised. Protein bands were identified by using
MALDI-TOF mass spectrometry by ITSI Biosciences Facility
(Pennsylvania, USA).
To obtain HeLa SCL, cells in 100mm culture dishes were
washed and scraped with 1ml of ice-cold PBS and collected
by centrifugation at 1500 rpm for 3min at 4◦C. The pellets
were re-suspended in 100µl of ice-cold lysis buffer (50mM
TrisHCl pH 7.6, 150mM sodium chloride, 1.0% NP-40 and 1X
protease inhibitor cocktail from Sigma) followed by 60 min of
constant agitation at 4◦C. Crude extracts were then centrifuged
at 12,000 rpm for 20 min at 4◦C and the supernatants were
collected. The protein content in soluble cell lysate (SCL) was
estimated by Bradford assay.
Immunoprecipitation (IP)
For IP experiments, 100mm culture dishes containing 1 × 107
HeLa cells were transfected with pMyc_BPE123 or the empty
vector using Lipofectamine 3000 (Life Technologies) according
to the manufacturer’s instructions. At 24 h post-transfection,
cells were scraped from the dishes and washed twice with ice-
cold PBS. The cells were lysed with 1ml ice-cold lysis buffer
containing 50mM Tris-HCl pH 7.6, 150mMNaCl, 1mM EDTA,
1mM DTT, 1% Triton X-100, 0.5% NP-40, and 1X protease
inhibitor cocktail (Sigma). After 30min on ice, the lysates were
centrifuged at 3000 × g for 15min at 4◦C. The supernatants
were then precleared by incubation with 25 µl protein G
coupled to magnetic beads (NEBS) for 1 h at 4◦C on a rotator.
Magnetic field was applied to pull beads to the side of the tube
and the supernatants were placed in clean tubes. Precleared
lysates were incubated with 1µg of rabbit anti-ENO-1 polyclonal
antibody (Santa Cruz) while rotating ON at 4◦C. Then, 25µl
of protein G coupled to magnetic beads were added for 2 h
while rotating at 4◦C. Magnetic beads were pulled aside and
supernatants were removed. Beads were washed three times
with 500µl of lysis buffer (the last wash without detergents)
and beads pellets were resuspended in 30µl of 3X SDS Sample
Loading Buffer (187.5mM Tris-HCl (pH 6.8), 6% (w/v) SDS,
30% glycerol, 150mM DTT, 0.03% (w/v) bromophenol blue,
2% β-mercaptoethanol). Samples were incubated at 95◦C for
5min and supernatants separated by magnetic field and loaded
on SDS-PAGE gels. Proteins were transferred to nitrocellulose
membranes and blots probed with a mouse serum raised against
BPE123. IR Dye secondary antibodies were used for detection on
the Odyssey Infrared Imaging System. Antibodies were diluted
in Tris buffered saline (TBS) 1% non fat milk, 0.05% Tween 20
solution.
Infection of Mouse Bone Marrow-Derived
Macrophages (BMDM)
The protocol to obtain BMDM from mice was approved
by the Committee on the Ethics of Animal Experiments of
the Universidad Nacional de San Martín, according with the
recommendations of the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health.
To obtain BMDM, bone marrow cells were isolated from
femurs of 6- to 10-week-old C57BL/6J female mice and
differentiated into macrophages as described (Celli et al.,
2005). Cells (5 × 104 per well) were seeded on coverslips
in 24-well plates in media without antibiotics 24 h before
infection. Infections with strains B. abortus 2308 mCherry,
1bpe123mCherry and ∆bpe123mCherry +pBPE123_3xFLAG
were carried out at multiplicity of infection (MOI) 30:1. Bacteria
were centrifuged onto cells at 400 × g for 10min. After 30min,
wells were gently washed three times with PBS and incubated for
120min with fresh medium containing 50µg ml-1 gentamicin
and 100µg ml-1 streptomycin to kill non-internalized bacteria.
Thereafter, antibiotics concentrations were decreased to 10µg
ml-1 gentamicin and 20µg ml-1 streptomycin. At the indicated
times, infected cells were either washed three times with PBS and
lysed with 500µl of 0.1% Triton X-100 in H2O (Sigma-Aldrich)
for CFU counts, or processed for immunofluorescence staining
as described below. Intracellular CFU counts were determined
by plating serial dilutions on TSA with the appropriated
antibiotic.
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ENO-1 Fluorescence Intensity
Quantification
Coverslips with infected BMDM were processed as already
described and probed with rabbit anti-ENO-1 (Santa Cruz)
and Alexa Fluor 488 goat anti-rabbit IgG (Molecular Probes,
Invitrogen) as secondary antibody. After immunofluorescence
labeling, the coverslips were mounted onto slides with FluorSave
(Calbiochem) and confocal images were acquired as described
above. Alpha-enolase fluorescence intensity was quantified in
acquired images like already described (Miserey-Lenkei et al.,
2001; Leterrier et al., 2004) and at least 100 intracellular Regions
of Interests (ROIs) were counted per strain and per time
post-infection. The ROIs were defined as a circle of 3µm of
diameter and centered in mCherry-tagged bacteria. A random
background was measured to normalize the mean intensity. To
avoid underestimation of the number of intracellular bacteria,
images analyzed were a z-projection of sum intensity and in all
cases the projected amount of slices were the same. The assays
were performed in triplicate.
RNA Interference
For RNAi depletion of ENO-1, pGShin2 vector was used.
This vector bears shRNA synthesis cassette under H1
promoter and enhanced green fluorescent protein (EGFP)
cDNA under the cytomegalovirus (CMV) promoter (Kojima
et al., 2004). DNA oligonucleotide primers were designed
according to recommendations (http://www.oligoengine.com
and https://rnaidesigner.lifetechnologies.com/rnaiexpress/) and
target a 19-nucleotide (nt) sequence selected within the human
ENO-1 gene (Uniprot accession no. PO06733). BLAST search
of human genome sequence databases (NCBI Unigene and EST
libraries) was performed to ensure that no other human gene
was targeted. The double-stranded DNA (dsDNA) was designed
as follows: a 19-nucleotide target sequence in both sense and
antisense orientations, separated by a 9-nucleotide spacer
sequence to form a hairpin dsRNA and flanked at either end by
BglII and HindIII restriction enzyme sites and the five repeats
of T as transcriptional termination signal. Oligonucleotides
targeting nt 413-431 (sense 5′GATCCCCTGGCAACTCTG
AAGTCATCTTCAAGAGA GATGACTTCAGAGTTGCCATT
TTT; antisense 5′AGCTAAAAATGGCAACTCTGAAGTCAT
CTCTCTTGAAGATGACTTCAGAGTTGCCAGGG) were
annealed and directionally cloned, by using the BglII/HindIII
sites, downstream the human H1 promoter in the pG-Shin2
vector. The resulting construct was named ENO-1 siRNA. As
a control, we used the scrambled shRNA with the sequences 5′
GATCCCCACGCGAGTCGACCATGTCA TTCAAGAGATGA
CATGGTCGACTCGCGTTTTTT (sense) and 5′ AGCTAAAAA
ACGCGAGTCGACCATGTCATCTCTTGAATGACATGG
TCGACTCGCGTGGG (antisense). All constructs were further
verified by DNA sequencing. Transfection of the recombinant
plasmids was carried out using Lipofectamine 3000 (Invitrogen)
according to the manufacturer’s protocols. ENO-1 silencing
in HeLa cells was confirmed by SDS-PAGE and Western Blot
probed with rabbit anti ENO-1 polyclonal antibody (Santa Cruz)
and mouse anti-GFP (Roche) for normalization. Additionally,
flow cytometry was used to estimate ENO-1 reduction in treated
cells. HeLa cells seeded at a density of 106 cells in 100mm
plates and transfected with ENO-1 siRNA plasmid or with Scr
siRNA control plasmid were harvested at 96 h post-transfection.
The cells were washed with ice cold PBS, fixed for 20min in
3% final PFA at room temperature and then permeabilized for
30min in 300µL of permeabilization buffer (PBS containing
0.5 % Saponin and 10% bovine serum). After incubation of the
permeabilized cells with rabbit anti ENO-1 polyclonal antibody
(Santa Cruz), the samples were washed and incubated with
Alexa Fluor 647 antibody (Molecular Probes, Invitrogen) for 30
min on ice. The preparation was fixed for 20min in 3% PFA
and then diluted to 1% PFA before analysis on a CyFlow Aria
cytometer (Partec). Data were analyzed using FlowJo software
v7.6.2. Transfected GFP-positive cells were gated to generate the
overlaid histograms.
Trypan Blue Exclusion Test for Cell Viability
At 48 h post-infection, HeLa cells depleted for ENO-1 or
transfected with the control plasmid were harvested, washed
twice with PBS and cell viability was assessed by trypan blue
exclusion assay (Strober, 2001).
Infection of SiRNA Treated HeLa Cells
At 24 h after transfection of HeLa cells with ENO-1 or Scr siRNA,
cells were infected with the indicated B. abortus 2308 strains at
MOI 1000:1 as described above for BMDM. To maintain the
silencing of ENO-1, HeLa cells were again transfected at 2 h
p.i. At the indicated times, infected cells were either washed
three times with PBS and lysed in 500µl of 0.1% Triton X-
100 (Sigma-Aldrich) in PBS for CFU counts or processed for
immunofluorescence like previously described. Intracellular CFU
counts were determined by plating serial dilutions on TSA with
the appropriated antibiotics. Rabbit anti-ENO-1 (Santa Cruz)
and Alexa Fluor 647 goat anti-rabbit IgG (Molecular Probes,
Invitrogen) were used to asses alpha-enolase depletion in treated
cells and quantificate intracellular bacteria in treated and control
cells by immunofluorescence confocal microscopy. At least 500
transfected cells (with ENO-1 or Scr siRNA plasmid) were scored
to analyze intracellular bacterial loads by confocal microscopy.
Transfected cells were identified by GFP expression andmCherry
bacteria were visualized in red.
Alpha-Enolase Activity Quantification
The assays were performed using ENO-1 Human Activity Assay
Kit (Abcam) following the manufacturer’s instructions. HeLa
cells were transfected with pMyc_BPE123 or pMyc empty vector
like previously described. Cells from the human promonocytic
cell line THP-1 were seeded in 6-well plates at 106 cells/well
and treated with 30 ng/ml phorbol 12-myristate 13-acetate
(PMA; Sigma) overnight; cells were allowed to adhere and
become differentiated into macrophages for 24 h before infection
with B. abortus strains 2308 mCherry, ∆bpe123mCherry and
∆bpe123mCherry + pBPE123_3xFLAG (MOI 30:1). Non-
infected cells were included as control. Infections were performed
like already described for BMDM and HeLa cells. Assays were
performed using cell extracts from transfected or infected cells
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according to the manufacturer’s instructions, and quantifications
were normalized to total protein contents determined by a
Coomassie (Bradford) protein assay (Pierce Science) using
bovine serum albumin (BSA) as a standard protein. ENO-1
proteins levels were determined by SDS-PAGE and Western
Blot with rabbit anti-ENO-1 antibodies (Santa Cruz) and mouse
anti-tubulin (Developmental Studies Hybridoma Bank, National
Institute of Child Health and Human Development, University
of Iowa) for normalization. In transfected cells, a serum raised
against BPE123 was used to assess expression of BPE123.
Statistical Analyses
Statistical analyses were performed with Prism 6 software
(GraphPad) with one-way ANOVA and Tukey’s post-test for
multiple comparisons or Student’s t-test to assess statistical
differences between two experimental data sets. P-values: ns, not
significant; ∗P < 0.05; ∗∗P< 0.01; ∗∗∗P < 0.001.
RESULTS
In vitro Interactions between BPE123 and
Host Cell Proteins
BPE123 is a 17 kDa-protein (153 aa) highly conserved in Brucella
and Ochrobactrum species, with less conserved homologs
(about 30% identity) in Bartonella and Phyllobacterium species
(Figure 1A). The protein contains a predicted signal peptide and
central coiled coil motif (CC) spanning amino acids 36-111. The
presence of a central coiled coil domain in BPE123 suggests that
this protein may be engaged in protein-protein interactions. For
this reason, we aimed to identify eukaryotic binding partners for
BPE123 by using purified His_BPE123 as a bait to pull down
proteins from HeLa soluble cell lysates. HeLa soluble cell lysates
(SCL) were incubated with cobalt chelate affinity resin preloaded
with His_BPE123 or with unloaded resin as a control. Bound
proteins were eluted with 300 mM imidazole, separated by SDS-
PAGE and analyzed by silver stain. Several differential bands were
FIGURE 1 | In vitro interaction analysis between His_BPE123 and host-cell proteins by pull-down assay. (A) Clustal Omega alignment of B. abortus
BPE123 and homologous hypothetical proteins (HP) from Ochrobactrum anthropi, Bartonella bacilliformis KC583, and Phyllobacterium sp. YR531. The red box
indicates the Sec secretion signal (predicted by PSORTb tool), the green box indicates the CC motif (predicted by COILS) and the blue box indicates the most
conserved region between the proteins. The asterisks indicate identical residues, double dots indicate strong similarity and the single dots indicate weaker similarity.
(B) HeLa soluble cell lysates (SCL) were incubated with cobalt chelate affinity resin preloaded with His_BPE123 or with unloaded resin. After washing, bound proteins
were eluted with 290 mM Imidazole. Samples containing eluates were resolved by SDS-PAGE and bands visualized by silver staining. The differential band visible in
the His_BPE123 eluate (arrow) was identified by LC/MS-MS as alpha-enolase (ENO-1). (C) Similarly prepared samples were resolved by SDS-PAGE, transferred to
nitrocellulose and immunoblotted with an anti-ENO-1 polyclonal antibody.
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detected after silver staining, but we focused in the most obvious
∼48-kDa band that co-eluted with His_ BPE123, but was absent
in the control lane. The band was excised and identified by Liquid
Chromatography/Mass Spectrometry as human alpha-enolase
(ENO-1) (Figure 1B). To confirm these results, the same samples
were analyzed by Western Blot with anti ENO-1 antibodies and
a band with molecular weight compatible with alpha-enolase
was detected (Figure 1C), thus validating the identity of the
differential band identified as ENO-1.
BPE123 Interacts with Host ENO-1 In vivo
To investigate in vivo the interaction between BPE123 and
ENO-1, we performed immunoprecipitation (IP) with HeLa
cells expressing Myc_BPE123 fusion. Protein complexes were
immunoprecipitated from whole cell lysates with anti-ENO-
1 antibody and subsequently analyzed by immonoblotting
with anti-BPE123 antibody. Western blotting demonstrated
the presence of BPE123 in the IP fraction of Myc_BPE123-
transfected HeLa cells, but not in the IP fraction of cells
transfected with the empty vector (Figure 2A).
α-Enolase is a key glycolytic/gluconeogenesis enzyme
that catalyzes the interconversion of 2-phosphoglycerate
to phosphoenolpyruvate. This isozyme is mainly localized
diffusedly in the cytoplasm and on the surface of several cell
types, where it acts as a plasminogen receptor. There is also
an alternatively spliced form that is expressed in the nucleus.
FIGURE 2 | In vivo interaction between BPE123 and host ENO-1. (A) IP with anti-ENO-1 antibodies were performed with HeLa cells transfected with
pMyc_BPE123 or the empty vector. The resulting IP fractions were resolved by SDS-PAGE and probed with anti-BPE123 polyclonal antibodies, showing the presence
of Myc_BPE123 in the IP fraction of pMyc_PE123 transfected cells (indicated by two asterisks) but not in the IP fraction of cells transfected with the empty vector.
Asterisks indicate bands corresponding to the heavy and light chains of immunoglobulin. (B) Representative confocal micrographs showing ENO-1 distribution in
HeLa cells transiently transfected for 24 h with a plasmid expressing Myc_BPE123 or Myc_SerB included as control. Transfected cells grown on coverslips were
stained with anti-ENO-1 and with anti-Myc antibody to visualize BPE123 or SerB. (C) Fluorescence intensity profiles (arbitrary units) across the traced lines are shown
for Myc_BPE123 or Myc_SerB (green) and ENO-1 (red).
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ENO-1 is considered amultifunctional protein and its subcellular
localization appears to be related to cellular functions distinct
from its well-established function in glycolysis/gluconeogenesis
(Díaz-Ramos et al., 2012). Analysis of ENO-1 distribution
by confocal immunofluorescence microscopy in HeLa cells
expressing BPE123 revealed a similar distribution for these
proteins as judged by the fluorescence intensity profiles
(Figure 2B, upper panel) in comparison with an unrelated Myc-
tagged protein (Figure 2B, lower panel). This result reinforces
IP results indicating that ENO-1 is an interacting partner for
BPE123.
ENO-1 Associates to BCVs in a
BPE123-Dependent Manner
To better characterize the interaction between BPE123 and
ENO-1, and given that BPE123 is localized to the BCVs
(Marchesini et al., 2011), we decided to analyze whether ENO-
1 is associated to BCVs and to quantify its association to these
intracellular compartments in cells infected with B. abortus wild
type, bpe123 deletion mutant (1bpe123) or the complemented
strain. In order to facilitate the analysis, Brucella strains
expressing the fluorescent protein mCherry under the control of
a constitutive promoter were used. For this purpose, mCherry-
tagged B. abortus 2308, 1bpe123, or the complemented strain
were used to infect bonemarrow-derivedmacrophages (BMDM).
Intracellular CFU counts for these strains in BMDMs are shown
in Figure S1. ENO-1 association to BCVs was quantified at 4
and 30 h p.i. and mean ENO-1 fluorescence intensities were
automatically measured (using arbitrary units) around manually
selected mCherry-tagged bacteria defined as regions of interest
(ROIs) in infected cells (see Materials and Methods). As can
be seen in Figures 3A,B, ENO-1 is associated to BCVs during
BMDM infection. This association increases during the time
course of the infection, as reflected from an increase in the
fluorescence intensities from 4 to 30 h post-infection. At this
time point, fluorescence intensity of ENO-1 associated to wild
type BCVs is significantly higher than fluorescence intensity of
ENO-1 in association with 1bpe123 BCVs. Complementation
of the mutant strain with a plasmid expressing BPE123 restored
the ability of this strain to associate to ENO-1. These results are
indicative of a role of BPE123 in recruitment of ENO-1 to BCVs
at the later stages of BMDM infection.
Host Cell ENO-1 Is Required for
Intracellular B. abortus Replication
To get insight into the role of ENO-1 in Brucella pathogenesis, we
down-regulated the expression of ENO-1 in HeLa cells infected
with B. abortus by using small interfering RNA technology.
Reduction of ENO-1 in treated cells was assessed by Western
Blot and flow cytometry, showing 78.95 ± 6.57% reduction
of ENO-1 protein levels in cells transfected with a plasmid
encoding for ENO-1 siRNA (Figure S2). It is important to
FIGURE 3 | ENO-1 accumulates in the vicinities of BCVs. (A) Quantification of fluorescence intensities (Arbitrary Units) of BCV-associated ENO-1 in BMDM
infected with the indicated strains of mCherry-tagged B. abortus at 4 and 30 h (p.i.). Quantitative analysis was based on examination of at least 500 infected cells. The
data represent analyses of the mean and standard deviations and are representative of two independent experiments. ***P < 0.001 (unpaired t-test). (B)
Representative confocal micrographs of bone marrow-derived macrophages infected with the indicated strains of mCherry-tagged B. abortus at 30 h p.i. Infected
cells grown on coverslips were stained with anti-ENO-1 antibody (green). Magnified insets show overlay color images of the boxed region. Scale bar, 5µm.
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mention that viability of cells depleted for ENO-1 was similar
to cells transfected with the control plasmid (Figure S3). ENO-
1 depleted cells were infected with mCherry-tagged B. abortus
2308,1bpe123 or the complemented strain. Inhibition of ENO-1
expression in cells infected with wild type or the complemented
strain induced a statistically significant reduction in bacterial
replication, as compared to cells transfected with scramble siRNA
(Figure 4A, Figure S4). This was not the case for1bpe123, which
showed similar replication levels under both treatments. Detailed
inspection and quantification of intracellular wild type bacteria
by immunofluorescence microscopy in ENO-1 depleted cells at
48 h post-infection, revealed a significant deleterious effect with
nearly 90% of the cells uninfected or containing less than 5
intracellular bacteria, and only small fraction showing clear signs
of bacterial replication (>5 bacteria). The observed defect was
related to the silencing of ENO-1, since at that time more than
70% of control cells harbor more than 5 intracellular bacteria,
indicating that bacterial replication had occurred (Figures 4B,C).
In agreement with CFU counts, quantification by confocal
microscopy revealed no significant differences in intracellular
bacterial distribution between ENO-1 depleted and Scr-treated
cells for 1bpe123, whereas nearly 4% of ENO-1 positive cells
were heavily infected by the complemented strain (Figure S5).
These results demonstrate that B. abortus expressing BPE123
replicates more efficiently in HeLa cells expressing ENO-1,
highlighting the role of this enzyme in Brucella intracellular
lifestyle.
ENO-1 Activity Is Enhanced by BPE123
Expression in HeLa Cells
In order to assess if the interaction between BPE123 and ENO-
1 has an effect on its enzymatic activity, we measured the
FIGURE 4 | ENO-1 depletion affects B. abortus intracellular replication. (A) Intracellular replication of mCherry-tagged B. abortus strains in HeLa cells
transfected with ENO-1 siRNA or scramble siRNA. CFU were enumerated at 4, 24, and 48 h post-infection (p.i.) and the data represents the changes in the CFU/ml
numbers at 48 h p.i. relative to CFU/ml at 4 h p.i. Data are means ± SD of a representative experiment performed in triplicate.**P < 0.01;***P < 0.001 (unpaired
t-test). (B) Quantification of ENO-1 or Scr siRNA treated HeLa cells infected with mCherry-tagged B. abortus 2308 containing less than 5 bacteria, between 5 and 10
bacteria, or more than 10 bacteria at 48 h p.i. Data are means ± SD of three independent experiments. **P < 0.01 (unpaired t-test). (C) Representative confocal
micrographs of HeLa cells transfected with scramble siRNA (upper panel) or ENO-1 siRNA (lower panel) and infected with wild type mCherry-tagged Brucella abortus
at 48 h p.i. Infected cells grown on coverslips were stained with anti-ENO-1 antibody (gray), bacteria were visualized in red and transfected cells in green. Scale bars,
5/10 µm.
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activity of the native enzyme in cell extracts of HeLa cells
transfected for 24 h with empty pCMV_Myc vector (control)
or with pCMV_Myc_BPE123. ENO-1 activity was found to
be significantly higher in cells ectopically expressing BPE123
(Figure 5A). Importantly, ENO-1 protein levels were similar
between control and cells expressing BPE123, indicating that
the observed difference is not due to increased enzyme amount
(Figure 5B, Figure S6A). This finding suggests that BPE123
enhances ENO-1 enzymatic activity.
ENO-1 Activation upon B. abortus Infection
Given that ENO-1 activity is enhanced upon ectopic expression
of BPE123 in HeLa cells, we sought to determine ENO-1 activity
in extracts of THP-1 macrophages infected with mCherry-tagged
B. abortus wild type, ∆bpe123 and the complemented strain. As
shown in Figure 6A, the three strains are able to invade and
replicate inside THP-1 macrophages. At 30 h post-infection, cells
were lysed and ENO-1 activity was measured like previously
described. Non-infected cells were included as control. Results
depicted in Figure 6B show that ENO-1 activity increases as a
consequence of the infection irrespective of the strain. However,
the activity is significantly higher in cells infected with the wild
type or with the complemented strain (Figure 6B), indicating
that BPE123 enhances alpha-enolase activity in the context of
Brucella infection, since ENO-1 protein levels determined by
Western Blot were similar among the four treatments (Figure 6C,
Figure S6B). These results are indicative of a role of translocated
BPE123 in the enhancement of alpha-enolase activity during
infection with B. abortus.
DISCUSSION
Type IV secretion systems are membrane-associated protein
complexes used by many Gram-negative pathogenic bacteria
including Brucella spp., Legionella pneumophila, Coxiella
burnetii, Bartonella spp., Helicobacter pylori, Bordetella pertussis,
and Rickettsia prowazekii, to translocate effector proteins that
either hijack or interfere with host cell pathways (Llosa et al.,
2009; Voth and Heinzen, 2009; de Jong and Tsolis, 2012; Voth
et al., 2012; Isaac and Isberg, 2014; Siamer and Dehio, 2015).
Brucella VirB system is one of the major virulence factors
described so far, being essential for bacterial intracellular
replication and colonization in experimentally infected mice
(Sieira et al., 2000; Comerci et al., 2001; Delrue et al., 2001;
O’Callaghan et al., 2002; Celli et al., 2003). In recent years, several
studies have successfully identified and characterized many VirB
effector proteins, a crucial step in our molecular understanding
of Brucella-host cell interaction (de Barsy et al., 2011; de Jong
et al., 2013; Myeni et al., 2013; Salcedo et al., 2013). Despite these
previous studies, the molecular mechanisms mediated by these
effector proteins are only beginning to be elucidated, as well as
the host factors that contribute to Brucella intracellular life.
In this study, we aimed to understand the role of BPE123
during B. abortus infection, and to achieve this we focused on
the identification of host cell proteins interacting with BPE123.
ENO-1 was identified as a host-cell interacting partner in a pull-
down experiment, and this interaction was further confirmed in
vivo by immunoprecipitation and confocal microscopy of HeLa
cells expressing BPE123.
Enolase (2-phospho-D-glycerate hydrolase) (EC 4.2.1.11) is
a dimeric enzyme of the pay-off phase of glycolysis and
gluconeogenesis pathways, in which it catalyzes the dehydration
of 2-phospho-D-glycerate to phosphoenolpyruvate and the
reverse reaction, respectively. Three different enolase isoforms
exist in mammals: alpha, beta and gamma-enolase, which are
encoded by three different genes: ENO1, ENO2 and ENO3.
α-enolase is the embryonic form expressed in most adult
tissues, while β-enolase is preferentially expressed in muscle
FIGURE 5 | BPE123 ectopic expression enhances ENO-1 activity in HeLa cells. (A) HeLa cells were transfected with pMyc empty vector (control) or
pMyc_BPE123 for 24 h, and alpha-enolase activity in cell lysates was measured by monitoring for NADH consumption in a coupled reaction as decrease in
absorbance at 340 nm. Data are means ± SD of three independent experiments. **P < 0.01 (unpaired t-test). (B) Western Blotting of lysates from HeLa cells
transfected for 24 h with pMyc or pMyc_BPE123, probed with anti-ENO-1, anti-BPE123, and anti-tubulin antibodies for normalization.
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FIGURE 6 | ENO-1 activation in B. abortus infected THP-1 macrophages. (A) Intracellular CFU counts of the indicated mCherry-tagged strains in THP-1
macrophages at 4, 24 and 48 h p.i. Data are means ± SD of three independent experiments. **P < 0.01 (ANOVA and Tukey’s multiple comparison test detected
statistically significant differences at 24 hs p.i. between ∆bpe123 and 2308, and between ∆bpe123 and the complemented mutant). (B) Quantification of ENO-1
activity in lysates of THP-1 macrophages infected with the indicated strains at 30 h p.i. by monitoring NADH consumption in a coupled reaction as decrease in
absorbance at 340 nm. Data are means ± SD of three independent experiments. ANOVA and Tukey’s multiple comparison test detected statistically significant
differences at 71 min (P = 0.0003) and 84 min (P = 0.0009) for all comparisons, except 2308 vs. ∆bpe123+pBPE123_3xFLAG; at 58 min (P = 0.01) non-infected
cells are statistically different from cells infected with ∆bpe123+pBPE123_3xFLAG. (C) Western Blotting of lysates from THP-1infected cells probed with anti-ENO-1
and anti-tubulin antibodies for normalization. Non-infected cells were included as control.
and γ-enolase is present in neurons and neuroendocrine tissues
(Giallongo et al., 1990, 1993; Oliva et al., 1991). Alpha-enolase
expression increases upon mitogenic stimulation in lymphocytes
(Giallongo et al., 1986), in hypoxic conditions (Semenza et al.,
1996) and after inflammatory stimuli and cytokines production
(Fontán et al., 2000; Scharte et al., 2003). Besides its main role
in glycolysis and gluconeogenesis, α-enolase is a multifunctional
protein displaying a range of dissimilar activities like hypoxic
stress protein in endothelial cells, heat shock protein (HSP48)
in the yeast Saccharomyces cerevisiae, lens crystalline and
autoimmune antigen (Moscato et al., 2000; Díaz-Ramos et al.,
2012). An alternative stop codon in ENO-1 gene produces a
37 kDa nuclear protein that binds c-myc P2 promoter and
functions as a transcriptional repressor (Feo et al., 2000). Besides
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its primary localization in the cytoplasm, α-enolase is also
expressed on the surface of a variety of eukaryotic cells, where
it functions as a plasminogen receptor regulating its activation
(Miles et al., 1991; Redlitz et al., 1995; Liu and Shih, 2007).
Plasminogen activation mediated by α-enolase plays important
roles in tissue remodeling, inflammatory response, pathogen
invasion and metastasis of tumor cells (Capello et al., 2011;
Díaz-Ramos et al., 2012).
Two recent studies have identified interactions between host
glycolytic enzymes and pathogen’s proteins. The first study
demonstrates that hepatitis C virus (HCV) non-estructural
protein NS5A interacts with cellular hexokinase 2 inducing an
enhancement of the catalytic parameters of the enzyme, which
might explain the aerobic glycolysis shift observed in HCV-
infected cells (Ramière et al., 2014). The second report shows
thatMycobacterium tuberculosis Early-Secreted Antigenic Target
(ESAT-6), a virulence factor and a secretory protein playing
important roles in pathogenesis, interacts with the macrophage
glycolytic enzymes alpha-enolase and phosphoglycerate kinase 1
(Singh et al., 2015).
ENO-1 was found associated to BCVs in a BPE123-dependent
manner at later times post-infection in BMDM. In these cells,
we observed delayed intracellular replication kinetics for the
mutant and the complemented strain in comparison to the wild
type. However, only the BPE123 expressing strains displayed an
increased association with ENO-1 at later times, ruling out an
effect of the replication rate on ENO-1 recruitment.
The relevance of alpha-enolase for the intracellular stages of
Brucella is highlighted by the reduced intracellular replication
rates of BPE123 expressing strains in ENO-1 depleted HeLa
cells. At this point, it could be speculated that BPE123-ENO-1
association serves to enhance ENO-1 activity to favor Brucella
replication. Consistent with this hypothesis, we found that ENO-
1 activity levels are increased in HeLa cells expressing BPE123.
More interestingly, we demonstrated that ENO-1 catalytic
activity is enhanced in THP-1 macrophages upon infection
with B. abortus, with BPE123 playing a critical role in this
phenomenon. The lack of effect in 1bpe123 replication rate
in ENO-1 depleted cells could be explained by the fact that
infection with this strain activates ENO-1 but to a lower extent,
and probably alternative mechanisms are supporting Brucella
replication.
Evidence presented herein suggests that interaction between
BPE123 and ENO-1induces structural and/or functional changes
accounting for the activation of host cell alpha-enolase. In this
scenario, it could be interesting to address host cell glycolysis
contribution to the intracellular survival of Brucella. Indeed,
a previous study by Fugier et al. demonstrated that another
enzyme of glycolysis, GAPDH, is recruited to the BCV and in
combination with ENO-1 are both necessary to support Brucella
intracellular replication (Fugier et al., 2009). More recently, a
study from Xavier et al. showed that during the chronic stage of
infection, B. abortus replicates more efficiently in Alternatively
Activated Macrophages (AAMs) than in Classically Activated
Macrophages (CAM), and this preference was related to the
ability of the pathogen to use the high availability of glucose
in AAMs (Xavier et al., 2013). A metabolic mutational study
carried out by Zuñiga-Ripa et al., indicated that gluconeogenesis
is dispensable for Brucella during the intracellular stage of
infection, whereas the triose phosphate pathway and the
tricarbolixic cycle seems to be relevant during this stage, which is
consistent with the idea that intracellular Brucellametabolizes 6C
sugars and probably amino acids provided by the host (Zúñiga-
Ripa et al., 2014). All these lines of evidence suggest that Brucella
has evolved sophisticated mechanisms to ensure its persistence
by manipulating the host-cell metabolism in its own benefits. In
this context, it should be interesting to address the mechanism
by which BPE123 affects the kinetic parameters of host ENO-1
and how this interaction modulates the outcome of the infection
process.
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